IL-1β promotes TGF-β1 and IL-2 dependent Foxp3 expression in regulatory T cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Ganesh, Balaji B ^a   Bhattacharya, Palash ^a   Gopisetty, Anupama ^a   Sheng, Jianrong ^a   Vasu, Chenthamarakshan ^a   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYROID GLAND; ANIMAL; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-1BETA; INTERLEUKIN-2; MICE; T-LYMPHOCYTES, REGULATORY; THYROGLOBULIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79960121264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021949     Document Type: Article

References (73)

1. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.
2. Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, et al. (2006) Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
3. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
4. Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, et al. (2007) Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104: 2821-2826.
5. Blanco P, Palucka AK, Pascual V, Banchereau J, (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19: 41-52.
6. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, et al. (1995) Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181: 817-821.
7. Steinman RM, (1988) Cytokines amplify the function of accessory cells. Immunol Lett 17: 197-202.
8. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, et al. (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32: 1-7.
9. Feldmann M, Maini RN, (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19: 163-196.
10. Awasthi A, Kuchroo VK, (2009) Th17 cells: from precursors to players in inflammation and infection. Int Immunol 21: 489-498.
11. Schnorrer P, Behrens GM, Wilson NS, Pooley JL, Smith CM, et al. (2006) The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A 103: 10729-10734.
12. Maldonado-Lopez R, Maliszewski C, Urbain J, Moser M, (2001) Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 167: 4345-4350.
13. Lahoud MH, Proietto AI, Gartlan KH, Kitsoulis S, Curtis J, et al. (2006) Signal regulatory protein molecules are differentially expressed by CD8- dendritic cells. J Immunol 177: 372-382.
14. Grohmann U, Fallarino F, Bianchi R, Belladonna ML, Vacca C, et al. (2001) IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol 167: 708-714.
15. Suss G, Shortman K, (1996) A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 183: 1789-1796.
16. Fazekas de St Groth B, (1998) The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today 19: 448-454.
17. Frick JS, Grunebach F, Autenrieth IB, (2010) Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6. Int J Med Microbiol 300: 19-24.
18. Hawiger D, Masilamani RF, Bettelli E, Kuchroo VK, Nussenzweig MC, (2004) Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20: 695-705.
19. Ganesh BB, Cheatem DM, Sheng JR, Vasu C, Prabhakar BS, (2009) GM-CSF-induced CD11c+CD8a-dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 21: 269-282.
20. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
21. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
22. Khattri R, Cox T, Yasayko SA, Ramsdell F, (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342.
23. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA, (2001) A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166: 7282-7289.
24. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA, (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol 169: 4183-4189.
25. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, et al. (2008) A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9: 632-640.
26. Yu A, Zhu L, Altman NH, Malek TR, (2009) A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30: 204-217.
27. Thornton AM, Donovan EE, Piccirillo CA, Shevach EM, (2004) Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172: 6519-6523.
28. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194: 769-779.
29. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, et al. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196: 1627-1638.
30. Trembleau S, Germann T, Gately MK, Adorini L, (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 16: 383-386.
31. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8: 500-508.
32. Lau AW, Biester S, Cornall RJ, Forrester JV, (2008) Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells. J Immunol 180: 3889-3899.
33. Yamazaki S, Steinman RM, (2009) Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J Dermatol Sci 54: 69-75.
34. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, et al. (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235-247.
35. Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS, (2009) Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol 131: 260-270.
36. Sheng JR, Li LC, Ganesh BB, Prabhakar BS, Meriggioli MN, (2008) Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis. Clin Immunol 128: 172-180.
37. Gangi E, Vasu C, Cheatem D, Prabhakar BS, (2005) IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174: 7006-7013.
38. Sheng JR, Li L, Ganesh BB, Vasu C, Prabhakar BS, et al. (2006) Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J Immunol 177: 5296-5306.
39. Esquivel PS, Rose NR, Kong YC, (1977) Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145: 1250-1263.
40. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, et al. (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193: 1285-1294.
41. Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, et al. IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol 22: 129-139.
42. Verginis P, Li HS, Carayanniotis G, (2005) Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J Immunol 174: 7433-7439.
43. Eriksson U, Kurrer MO, Sebald W, Brombacher F, Kopf M, (2001) Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol 167: 5464-5469.
44. Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L, (2003) IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J Immunol 170: 5491-5501.
45. Grabie N, Delfs MW, Westrich JR, Love VA, Stavrakis G, et al. (2003) IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest 111: 671-680.
46. Gianoukakis AG, Khadavi N, Smith TJ, (2008) Cytokines, Graves' disease, and thyroid-associated ophthalmopathy. Thyroid 18: 953-958.
47. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
48. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
49. Guo L, Wei G, Zhu J, Liao W, Leonard WJ, et al. (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 106: 13463-13468.
50. Lee WW, Kang SW, Choi J, Lee SH, Shah K, et al. (2010) Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 115: 530-540.
51. Brinster C, Shevach EM, (2008) Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells. J Leukoc Biol 84: 480-487.
52. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351: 2069-2079.
53. Brahmachari S, Pahan K, (2009) Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183: 2045-2058.
54. Dinarello CA, (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
55. Johnson VJ, Yucesoy B, Luster MI, (2005) Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 116: 851-858.
56. O'Sullivan BJ, Thomas HE, Pai S, Santamaria P, Iwakura Y, et al. (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176: 7278-7287.
57. Turnquist HR, Sumpter TL, Tsung A, Zahorchak AF, Nakao A, et al. (2008) IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J Immunol 181: 62-72.
58. Makino M, Maeda Y, Mukai T, Kaufmann SH, (2006) Impaired maturation and function of dendritic cells by mycobacteria through IL-1beta. Eur J Immunol 36: 1443-1452.
59. Hoffmann P, Boeld TJ, Eder R, Huehn J, Floess S, et al. (2009) Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 39: 1088-1097.
60. Li MO, Flavell RA, (2008) TGF-beta: a master of all T cell trades. Cell 134: 392-404.
61. Korn T, Bettelli E, Oukka M, Kuchroo VK, (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485-517.
62. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
63. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY, (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6: 1142-1151.
64. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM, (2007) Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178: 4022-4026.
65. Nakamura K, Kitani A, Strober W, (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194: 629-644.
66. Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, et al. (2006) Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A 103: 2758-2763.
67. Matsumura T, Hayashi H, Takii T, Thorn CF, Whitehead AS, et al. (2004) TGF-beta down-regulates IL-1alpha-induced TLR2 expression in murine hepatocytes. J Leukoc Biol 75: 1056-1061.
68. Choi KC, Lee YS, Lim S, Choi HK, Lee CH, et al. (2006) Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat Immunol 7: 1057-1065.
69. Lim WH, Toothman J, Miller JH, Tallents RH, Brouxhon SM, et al. (2009) IL-1beta inhibits TGFbeta in the temporomandibular joint. J Dent Res 88: 557-562.
70. Lu T, Tian L, Han Y, Vogelbaum M, Stark GR, (2007) Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Proc Natl Acad Sci U S A 104: 4365-4370.
71. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW, (1992) Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha. J Immunol 149: 103-106.
72. Andriamanalijaona R, Felisaz N, Kim SJ, King-Jones K, Lehmann M, et al. (2003) Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. Arthritis Rheum 48: 1569-1581.
73. Yue TL, Wang XK, Olson B, Feuerstein G, (1994) Interleukin-1 beta (IL-1 beta) induces transforming growth factor-beta, (TGF-beta 1) production by rat aortic smooth muscle cells. Biochem Biophys Res Commun 204: 1186-1192.